Prevalence of Hepatitis C Infection among Hemodialysis Patients in Karbala
DOI:
https://doi.org/10.59675/M323Keywords:
viral C hepatitis, dialysis, risk factors, and blood transfusionAbstract
Liver diseases associated with the hepatitis C virus (HCV) significantly contribute to mortality and morbidity in patients with end-stage renal disease undergoing dialysis. HCV infection may result in acute or chronic hepatitis, cirrhosis, and/or hepatocellular cancer. The incidence of hepatitis infections in the dialysis units of Imam Hussein City in Karbala has significantly increased from 2021 to 2023. Aim: Determine the HCV infection burden in hemodialysis patients in Imam Hussein Medical City from 2021-2023 and review the main risk factors associated with HCV infection in those patients. Method: Analytical cross-section study in hemodialysis units (Adel Al-Sabbah and Habeeb bin Mudhaher Al-Asdi centers) in Imam Hussein Medical City, Karbala, Iraq, from 2021 to 2023. These centers offer hemodialysis health services for residents of Karbala. Result: The demographic attributes of 122 hemodialysis patients, both with and without hepatitis C infection, at Imam Hussein Medical City were examined. The prevalence of hepatitis C among patients on dialysis was (10.37%).
A significant difference was observed in the occupation distribution between the two groups. Self-employed individuals were more likely to have Hepatitis C infection compared to other occupational groups. The study shows that dialysis in other centers, surgical operations, blood transfusion, and duration of dialysis are statistically significant risk factors for HCV infection. Conclusions: HCV transmission in the hemodialysis unit is multifactorial. Dialysis in other centers, surgical operations, blood transfusion, and duration of dialysis are risk factors for HCV infection.
References
Sinjari HY, Bakr KA. Prevalence and risk factors of hepatitis B and C virus infections among patients undergoing hemodialysis in Kurdistan, Iraq. Hepat Mon. 2018;18(5).
Kerollos M, et al. Prevalence and seroconversion of hepatitis C among hemodialysis patients in Assiut governorate, Egypt. Egypt J Intern Med. 2020; 32:2.
Taherkhani R, Farshadpour F. Epidemiology of hepatitis C virus in Iran. World J Gastroenterol. 2015;21:10790-816.
Shamsdin SA, Fatahi MR, Ansari AR, Safarpour AR. Prevalence of HBV, HCV, and HIV infections among patients undergoing hemodialysis in Fasa, Iran: A six-year follow-up study. Middle East J Dig Dis. 2022;14(3):317-22.
Ramzi ZS, Abdulla AA, Al-Hadithi T, Al-Tawil N. Prevalence and risk factors for hepatitis C virus infection in hemodialysis patients in Sulaimani. Zanco J Med Sci. 2010;14(1):44-50.
Bhopal RS. Concepts of Epidemiology: Integrating the ideas, theories, principles, and methods of epidemiology. 3rd ed. Oxford: Oxford University Press; 2016.
Greenberg KI, Choi MJ. Hemodialysis emergencies: Core curriculum. Am J Kidney Dis. 2021;77(5):796-809.
Alzabadi H, Rahal H, Fuqaha R. Hepatitis B and C prevalence among hemodialysis patients in the West Bank hospitals, Palestine. BMC Infect Dis. 2016;16:41.
Jassim NA, Athbi HA. Prevalence and risk factors for hepatitis C and B viruses infection among hemodialysis patients in Holy Karbala, Iraq. Kufa J Nurs Sci. 2015;5(3):4.
Khattab OS. Prevalence and risk factors for hepatitis C virus infection in hemodialysis patients in an Iraqi renal transplant center. Saudi J Kidney Dis Transpl. 2008;19(1):110-5.
Amber AA, Al-Kaseer E, Al-Diwan J. Hepatitis C virus infection among patients in hemodialysis unit at Baghdad Teaching Hospital. Iraqi Med J. 2021;67(2):51-6.
Al-Muramdy WHK. Prevalence rate of hepatitis C virus and hepatitis B virus infection in Iraqi patients on hemodialysis: Cross-sectional study. Medico-Legal Update. 2020;20(3):1340-5.
Hussein MM, Al-Sabaagh SJ, Khalaf AM. Hepatitis B and C virus prevalence and risk factors among hemodialysis patients in Al-Muthanna city, Iraq. AIP Conf Proc. 2024. https://doi.org/10.1063/5.0191733
Naif AN, et al. Prevalence and risk factors for hepatitis C and B virus infection among hemodialysis patients in Iraq. AIP Conf Proc. 2023. https://doi.org/10.1063/5.0150759
Assarehzadegan MA, Shakerinejad G, Noroozkohnejad R. Prevalence of hepatitis C and B infection and HCV genotypes among hemodialysis patients in Khuzestan province, southwest Iran. Saudi J Kidney Dis Transpl. 2009;20:681-4.
Elamin S, Abu-Aisha H. Prevention of hepatitis B virus and hepatitis C virus transmission in hemodialysis centers. Arab J Nephrol Transplant. 2011;4(1):35-47.
Alashek WA, McIntyre CW, Taal MW. Hepatitis B and C infection in hemodialysis patients in Libya: Prevalence, incidence and risk factors. BMC Infect Dis. 2012;12:265.
Sarhan II, Kamel CR. Prevalence of hepatitis C virus seroconversion among hemodialysis patients in Egypt. Egypt Liver J. 2015;3(2):34-9.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Academic International Journal of Medical Sciences
This work is licensed under a Creative Commons Attribution 4.0 International License.
